Pricing
Pricing

Lightstone Ventures

COMPARE

Overview

Number of Exits 
5
CB Rank (Investor) 
9,443
Lightstone Ventures
Lightstone Ventures is a leading global venture capital firm.
Categories 
Biotechnology, Health Care, Medical Device, Pharmaceutical
Headquarters Regions 
San Francisco Bay Area, Silicon Valley, West Coast
Founded Date 
Jan 1, 2012
Operating Status 
Active
Number of Employees 
11-50
Investor Type 
Venture Capital
Investment Stage 
Early Stage Venture
Number of Exits 
5
Website 
lightstonevc.com
LinkedIn 
View on LinkedIn
Phone Number 
617.933.3769

Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.

Find your next opportunity with Crunchbase Pro + Data Boost

  • Advanced Search - Find prospects with 200+ premium search filters
  • Premium Insights - View competitors, tech stack, IT spend and more
  • Monitor & Track - Get automatic email alerts on opportunities

Investments

Number of Investments 
28
Number of Lead Investments 
12
Lightstone Ventures has made 28 investments. Their most recent investment was on Oct 22, 2018, when they invested $87M in Earlens Corporation.

Exits

Number of Exits 
5
Lightstone Ventures has had 5 exits. Lightstone Ventures's most notable exits include Ra PharmaceuticalsCatabasis Pharmaceuticals, and Flex Pharma.
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics™, a new drug class combining the properties and benefits of antibodies and small molecules.
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Flex Pharma
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Claret Medical
Claret Medical develops cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI) and other procedures.
Nimbus Apollo
Nimbus Apollo, Inc. research and develops drugs that treats non-alcoholic steatohepatitis.

Funds Raised

Number of Funds 
3
Total Fund Raised 
$472M
Lightstone Ventures has raised a total of $472M across 3 funds, their latest being Fund II. This fund was announced on Sep 20, 2017 and raised a total of $250M.
Announced Date  
Fund Name  
Money Raised  
Sep 20, 2017
Fund II
$250M
Feb 17, 2016
Lightstone Singapore, L.P.
$50M
May 1, 2014
Lightstone Ventures I LP
$172M

Current Team

Number of Current Team Members 
11
Lightstone Ventures has 11 current team members, including CEO, Lightstone Singapore Pte. Ltd. Ken Noonan.
Ken Noonan
CEO, Lightstone Singapore Pte. Ltd.
Jason Lettmann
General Partner
Jean George
General Partner
Stacy Enxing Seng
Venture Partner
Hank Plain
General Partner
Caroline Gaynor
Vice President
Lara Abbaschian
Vice President
Wen Qi Ho
Associate

Past Team

Number of Past Team Members 
5
Lightstone Ventures has 5 past team members, including CFO Adam Bruce.
Person Name  
Title At Company  
Start Date  
End Date  
Adam Bruce
CFOJan 2012Aug 2017
Isabella Zhang
Investment Professional20162016
Anna Turetsky
Associate
Jim Broderick
PartnerMar 1, 2013
Juan-Pablo Mas
Vice PresidentDec 1, 2011

Related Hubs

Website Tech Stack by BuiltWith

Lightstone Ventures is actively using 15 technologies for its website. These include Google Analyticsnginx, and AJAX Libraries API.

Web Traffic by SimilarWeb

Lightstone Ventures is ranked 6,537,207 among websites globally based on its 1,455 monthly web visitors.

Interest Signals by Bombora

Lightstone Ventures employees are showing high interest in Cover Letters.

Competitors & Revenue by Owler

IT Spend by Aberdeen

Recent News & Activity

Number of Articles 
20
Date
Activity
Sign up for a free Crunchbase account to follow and track profiles you care about.


Terms of Service | Privacy Policy | © 2019 Crunchbase Inc. All Rights Reserved.